Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-(4-fluoro-phenylazo)-5-imino-5H-pyrazol-3-ylamine is a synthetic small molecule belonging to the fluorobenzenes chemical class. It is characterized by the presence of a fluoro-substituted phenylazo group linked to an imino-pyrazole core. The compound has been identified as an experimental agent that targets methionine aminopeptidase, an enzyme involved in protein processing and maturation. Its primary use appears to be in research settings rather than clinical or therapeutic applications[3][1]. No approved medical indications or marketed formulations are currently associated with this compound.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4-(4-fluoro-phenylazo)-5-imino-5H-pyrazol-3-ylamine.